Report an error

Spotted something inaccurate in “GLP-1 Agonists Cut CV Risk, But Anti-Inflammatory Mechanism Remains Unproven in Humans”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.